Tenax Therapeutics (TENX) Tops Q3 EPS by 2c
Get Alerts TENX Hot Sheet
Join SI Premium – FREE
Tenax Therapeutics (NASDAQ: TENX) reported Q3 EPS of ($0.15), $0.02 better than the analyst estimate of ($0.17).
For earnings history and earnings-related data on Tenax Therapeutics (TENX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
- FirstService (FSV) Tops Q2 EPS by 1c
- Biogen (BIIB) tops earnings expectations but revenue falls short
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!